Overview
About Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options.
Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
Headquarters
New York, NYWebsite
http://axsome.comCompany Size
201-500 employeesIndustry
Biotechnology ResearchCompany Type
Public CompanyFounded
2012Specialties
Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity DisorderJobs
Specialty Account Manager, Symbravo (Salt Lake City N, UT)
Axsome Therapeutics, Inc.
Salt Lake City, UT
Regional Business Director, Sunosi (Appalachia Region)
Axsome Therapeutics, Inc.
Nashville, TN
National Training Manager, Psychiatry (Great Lakes Region)
Axsome Therapeutics, Inc.
Milwaukee, WI
National Training Manager, Psychiatry (Appalachia & Northeast Regions)
Axsome Therapeutics, Inc.
Cleveland, OH
National Training Manager, Psychiatry (West Region)
Axsome Therapeutics, Inc.
San Francisco, CA